Letter: Baseline age on antiviral treatment may significantly influence the clinical response of children with chronic hepatitis B

LINKED CONTENT This article is linked to Wu et al papers. To view these articles, visit https://doi.org/10.1111/apt.17667 and https://doi.org/10.1111/apt.17843

Saved in:
Bibliographic Details
Published inAlimentary pharmacology & therapeutics Vol. 59; no. 3; pp. 423 - 424
Main Authors Li, Jing, Wu, Yaxin, Wang, Fu‐Sheng
Format Journal Article
LanguageEnglish
Published England Wiley Subscription Services, Inc 01.02.2024
Subjects
Antiviral Agents - therapeutic use
Child
children
clinical response
HBV
Hepatitis B
Hepatitis B, Chronic - drug therapy
Humans
clinical response
children
HBV
Online AccessGet full text

Cover

More Information
Summary:LINKED CONTENT This article is linked to Wu et al papers. To view these articles, visit https://doi.org/10.1111/apt.17667 and https://doi.org/10.1111/apt.17843
Bibliography:SourceType-Scholarly Journals-1
content type line 14
ObjectType-Editorial-2
ObjectType-Commentary-1
ObjectType-Correspondence-1
ObjectType-Commentary-2
content type line 23
ISSN:0269-2813
1365-2036
1365-2036
DOI:10.1111/apt.17830